<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Toxic Alcohol Ingestion - Ethylene Glycol</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->6/8/2012</div></div><div class="card__content"><h1 id="toxic-alcohol-ingestion-ethylene-glycol">Toxic Alcohol Ingestion: Ethylene Glycol</h1>
<p>General concepts for all 3 toxic alcohols</p>
<ul>
<li>Parent compounds (not metabolites) cause high osmolal gap</li>
<li>When NAD depleted, pyruvate converts to lactate, which then causes lactic acidosis</li>
<li>See metabolism diagram below</li>
</ul>
<h2 id="ethylene-glycol-eg-factoids">Ethylene Glycol (EG): Factoids</h2>
<p>Found in antifreeze, coolants, deicing solutions, ink in stamp pads and ballpoint pens</p>
<p><strong>Pharmacology</strong>:</p>
<ul>
<li>Peak serum concentration 1-4 hours, elimination half-life 3 hours</li>
<li>Minimum lethal dose 1-1.5 mL/kg </li>
<li>Metabolites (eg. oxalate acid) cause toxicity, but do NOT cause osmolal gap</li>
</ul>
<p><strong>Labs:</strong> </p>
<ul>
<li>High anion gap metabolic acidosis and high osmolal gap (early in patient course)</li>
</ul>
<h2 id="classic-presentation">Classic Presentation</h2>
<ol>
<li>Altered mental status</li>
<li>Hypocalcemia</li>
<li>Oxalate crystals in urine</li>
</ol>
<p><strong>Common Signs and Symptoms</strong></p>
<ul>
<li><strong>Neurologic</strong> – Nausea and vomiting, inebriation with euphoria, nystagmus, ataxia, myoclonic jerks… then CNS depression, hypotonia, seizures, coma</li>
<li><strong>Cardiopulmonary</strong> – Hyperventilation from respiratory compensation of acidosis, hypoxia from heart failure, multiorgan failure, ARDS</li>
<li><strong>Renal</strong> – Flank pain, acute tubular necrosis, renal failure</li>
</ul>
<h2 id="management">Management</h2>
<ul>
<li><strong>Goal</strong>: Prevent further formation of (<span class="drug">fomipezole</span>) &amp; eliminate toxic metabolites (dialysis)</li>
<li><strong>Antidote</strong>: <span class="drug">Fomipezole</span> inhibits alcohol dehydrogenase (alternative antidote= ethanol)</li>
<li><strong>Loading dose</strong>: 15 mg/kg IV</li>
<li><strong>Maintenance dose</strong>: 10 mg/kg IV every 12 hours x 2 days </li>
</ul>
<h2 id="american-academy-of-clinical-toxicology-guidelines">American Academy of Clinical Toxicology guidelines</h2>
<p><strong>Indications for treatment of EG poisoning with FOMIPEZOLE: (any of following)</strong></p>
<ul>
<li>Documented plasma ethylene glycol &gt;20 mg/dL</li>
<li>Documented recent hx of ingesting toxic EG amounts and osmolal gap &gt;10 mOsm/L</li>
<li><p>Strong suspicion of EG poisoning and at least 2 criteria:</p>
<ol>
<li>Arterial pH &lt;7.3</li>
<li>Serum bicarbonate &lt;20 mEq/L</li>
<li>Osmolal gap &gt;10 mOsm/L</li>
<li>Urine oxalate crystal present</li>
</ol>
</li>
</ul>
<p><strong>Indications for treatment of EG toxicity with HEMODIALYSIS: (any of following)</strong></p>
<ol>
<li>Deteriorating clinical status despite supportive tx PLUS metabolic acidosis (arterial pH &lt; 7.25-7.3)</li>
<li>Acute kidney injury with serum Cr &gt; 3 mg/dL or increase in serum Cr by 1 mg/dL</li>
<li>Acid-base/electrolyte abnormalities unresponsive to standard tx</li>
<li>Old recommendation: EG level &gt; 50 mg/dL</li>
</ol>
<p><em>Note:</em> <span class="drug">Fomipezole</span> without hemodialysis is an option if normal renal function AND no metabolic acidosis</p>
<h2 id="metabolism-of-alcohols">Metabolism of Alcohols</h2>
<p><img src="https://aliemcards.netlify.com/media/ethylene-glycol_image-1.png" alt="Metabolism of alcohols drawing"></p>
<h2 id="references">References</h2>
<ul>
<li>Marraffa JM, Cohen V, Howland MA. Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm. 2012 Feb 1;69(3):199-212. doi: 10.2146/ajhp110014. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=22261941">PubMed</a>]</li>
<li>Kraut JF, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008 Jan;3(1):208-25. Epub 2007 Nov 28. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18045860">PubMed</a>]</li>
<li>Jammalamadaka D, Raissi S. Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 2010 Mar;339(3):276-81. doi: 10.1097/MAJ.0b013e3181c94601. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=20090509">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"ethylene-glycol","title":"Toxic Alcohol Ingestion - Ethylene Glycol","authors":["Michelle Lin, MD"],"categories":[{"slug":"toxicology","name":"Toxicology"}],"created":"2012/06/08","updated":null,"body":"\n# Toxic Alcohol Ingestion: Ethylene Glycol\n\nGeneral concepts for all 3 toxic alcohols\n\n-  Parent compounds (not metabolites) cause high osmolal gap\n-  When NAD depleted, pyruvate converts to lactate, which then causes lactic acidosis\n-  See metabolism diagram below\n\n## Ethylene Glycol (EG): Factoids\n\nFound in antifreeze, coolants, deicing solutions, ink in stamp pads and ballpoint pens\n\n**Pharmacology**:\n\n- Peak serum concentration 1-4 hours, elimination half-life 3 hours\n- Minimum lethal dose 1-1.5 mL/kg \n- Metabolites (eg. oxalate acid) cause toxicity, but do NOT cause osmolal gap\n\n**Labs:** \n\n- High anion gap metabolic acidosis and high osmolal gap (early in patient course)\n\n## Classic Presentation \n\n1. Altered mental status\n2. Hypocalcemia\n3. Oxalate crystals in urine\n\n**Common Signs and Symptoms**\n\n- **Neurologic** – Nausea and vomiting, inebriation with euphoria, nystagmus, ataxia, myoclonic jerks… then CNS depression, hypotonia, seizures, coma\n- **Cardiopulmonary** – Hyperventilation from respiratory compensation of acidosis, hypoxia from heart failure, multiorgan failure, ARDS\n-  **Renal** – Flank pain, acute tubular necrosis, renal failure\n\n## Management\n\n- **Goal**: Prevent further formation of (\u003cspan class=\"drug\"\u003efomipezole\u003c/span\u003e) \u0026 eliminate toxic metabolites (dialysis)\n- **Antidote**: \u003cspan class=\"drug\"\u003eFomipezole\u003c/span\u003e inhibits alcohol dehydrogenase (alternative antidote= ethanol)\n- **Loading dose**: 15 mg/kg IV\n- **Maintenance dose**: 10 mg/kg IV every 12 hours x 2 days \n\n## American Academy of Clinical Toxicology guidelines\n\n**Indications for treatment of EG poisoning with FOMIPEZOLE: (any of following)**\n- Documented plasma ethylene glycol \u003e20 mg/dL\n- Documented recent hx of ingesting toxic EG amounts and osmolal gap \u003e10 mOsm/L\n- Strong suspicion of EG poisoning and at least 2 criteria:\n\n  1. Arterial pH \u0026lt;7.3\n  2. Serum bicarbonate \u0026lt;20 mEq/L\n  3. Osmolal gap \u003e10 mOsm/L\n  4. Urine oxalate crystal present\n\n**Indications for treatment of EG toxicity with HEMODIALYSIS: (any of following)**\n\n1. Deteriorating clinical status despite supportive tx PLUS metabolic acidosis (arterial pH \u0026lt; 7.25-7.3)\n2. Acute kidney injury with serum Cr \u003e 3 mg/dL or increase in serum Cr by 1 mg/dL\n3. Acid-base/electrolyte abnormalities unresponsive to standard tx\n4. Old recommendation: EG level \u003e 50 mg/dL\n\n_Note:_ \u003cspan class=\"drug\"\u003eFomipezole\u003c/span\u003e without hemodialysis is an option if normal renal function AND no metabolic acidosis\n\n## Metabolism of Alcohols\n\n![Metabolism of alcohols drawing](https://aliemcards.netlify.com/media/ethylene-glycol_image-1.png)\n\n## References\n\n- Marraffa JM, Cohen V, Howland MA. Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm. 2012 Feb 1;69(3):199-212. doi: 10.2146/ajhp110014. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=22261941)]\n- Kraut JF, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008 Jan;3(1):208-25. Epub 2007 Nov 28. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=18045860)]\n- Jammalamadaka D, Raissi S. Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 2010 Mar;339(3):276-81. doi: 10.1097/MAJ.0b013e3181c94601. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=20090509)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"ethylene-glycol"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>